Gastric Cancer

, Volume 20, Issue 6, pp 940–947 | Cite as

Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case–control study in the Chinese population

  • Tian Tian
  • Ling Xiao
  • Jiangbo Du
  • Xun Zhu
  • Yayun Gu
  • Na Qin
  • Caiwang Yan
  • Li Liu
  • Hongxia Ma
  • Yue Jiang
  • Jiaping Chen
  • Hao Yu
  • Juncheng Dai
Original Article

Abstract

Background

The cysteinyl transfer RNA synthetase gene (CARS) is located on chromosome band 11p15.5, which is an important tumor-suppressor gene region. Mutations in CARS have been identified in many kinds of cancers; however, evidence for a relationship between genetic variants in CARS and gastric cancer at the population level is still lacking. Thus, we explored the association of variants in CARS with gastric cancer using a two-stage case–control strategy in Chinese.

Methods

We undertook a two-stage case–control study to investigate the association between polymorphisms in CARS and risk of gastric cancer with use of an Illumina Infinium® BeadChip and an ABI 7900 system.

Results

Four single nucleotide polymorphisms (SNPs) were significantly associated with gastric cancer risk in both the discovery stage and the validation stage after adjustment for age and sex. In addition, the combined results of the two stages showed these SNPs were related to gastric cancer risk (P false discovery rate ≤ 0.001 for rs384,490, rs729662, rs2071101, and rs7394702). In silico analyses revealed that rs384490 and rs7394702 could affect transcription factor response elements or DNA methylation of CARS, and rs729662 was associated with the prognosis of gastric cancer. Additionally, expression quantitative trait loci analysis showed rs384490 and rs729662 might alter expression of CARS-related genes.

Conclusions

The potential functional SNPs in CARS might influence the biological functions of CARS or CARS-related genes and ultimately modify the occurrence and development of gastric cancer in Chinese. Further large-scale population-based studies or biological functional assays are warranted to validate our findings.

Keywords

Gastric cancer Susceptibility CARS Polymorphism Genetic association 

Notes

Acknowledgements

This work was funded by National Natural Science of China (81521004, 81230067, 81573238, 81422042, 81373090, 81302107), the Science Foundation for Distinguished Young Scholars of Jiangsu (BK20130042), Excellent Youth Foundation of Jiangsu (BK20160095), Jiangsu Province Clinical Science and Technology Projects (BL2012008), Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (15KJA330002), the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) and the Top-Notch Academic Programs Project of Jiangsu Higher Education Institution. The authors thank all study participants, research staff, and students who participated in this work.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Human rights statement

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent was obtained from all patients for their being included in the study.

Supplementary material

10120_2017_717_MOESM1_ESM.doc (490 kb)
Supplementary material 1 (DOC 490 kb)

References

  1. 1.
    Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64:1881–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn. 2009;3:585–96.CrossRefPubMedGoogle Scholar
  3. 3.
    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMedGoogle Scholar
  4. 4.
    Strong VE, Wu AW, Selby LV, Gonen M, Hsu M, Song KY, et al. Differences in gastric cancer survival between the U.S. and China. J Surg Oncol. 2015;112:31–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989;321:1562–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Thrumurthy SG, Chaudry MA, Hochhauser D, Mughal M. The diagnosis and management of  gastric cancer. BMJ. 2013;347:f6367.CrossRefPubMedGoogle Scholar
  7. 7.
    Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet. 2011;43:1215–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010;42:764–7.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Sun P, Du J, Zhu X, Ren C, Xie L, Dai N, et al. Genetic variation in the 3′-untranslated region of NBN gene is associated with gastric cancer risk in a Chinese population. PLoS One. 2015;10:e0139059.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Hayano M, Yang WS, Corn CK, Pagano NC, Stockwell BR. Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation. Cell Death Differ. 2016;23:270–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Kim YW, Kwon C, Liu JL, Kim SH, Kim S. Cancer association study of aminoacyl-tRNA synthetase signaling network in glioblastoma. PLoS One. 2012;7:e40960.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kim S, You S, Hwang D. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer. 2011;11:708–18.CrossRefPubMedGoogle Scholar
  14. 14.
    Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest. 2003;83:1255–65.CrossRefPubMedGoogle Scholar
  15. 15.
    Hu RJ, Lee MP, Connors TD, Johnson LA, Burn TC, Su K, et al. A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes. Genomics. 1997;46:9–17.CrossRefPubMedGoogle Scholar
  16. 16.
    Reid LH, Davies C, Cooper PR, Crider-Miller SJ, Sait SN, Nowak NJ, et al. A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics. 1997;43:366–75.CrossRefPubMedGoogle Scholar
  17. 17.
    Zhao B, Bepler G. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer. Oncogene. 2001;20:8154–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009;37:W600–5.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B. 1995;57:289–300.Google Scholar
  20. 20.
    GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580–5.CrossRefGoogle Scholar
  21. 21.
    Reid LH, West A, Gioeli DG, Phillips KK, Kelleher KF, Araujo D, et al. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms’ tumor assay. Hum Mol Genet. 1996;5:239–47.CrossRefPubMedGoogle Scholar
  22. 22.
    Henry I, Grandjouan S, Couillin P, Barichard F, Huerre-Jeanpierre C, Glaser T, et al. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A. 1989;86:3247–51.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Bepler G, Garcia-Blanco MA. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc Natl Acad Sci U S A. 1994;91:5513–7.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V, et al. Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer. 1995;72:696–701.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Gabra H, Watson J, Eccles D, Taylor L, Taylor K, Cohen B, et al. A statistical analysis of chromosome 11 and 17 loss of heterozygosity in epithelial ovarian cancer. Int J Oncol. 1996;8:625–31.PubMedGoogle Scholar
  26. 26.
    Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, et al. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res. 2001;61:7943–9.PubMedGoogle Scholar
  27. 27.
    Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22:1790–7.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, et al. TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature. 2015;520:697–701.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Errico A. Colorectal cancer: POLR2A deletion with TP53 opens a window of opportunity for therapy. Nat Rev Clin Oncol. 2015;12:374.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhou Y, Du WD, Chen G, Ruan J, Xu S, Zhou FS, et al. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol. 2012;138:939–45.CrossRefPubMedGoogle Scholar
  32. 32.
    Weinhold N, Meissner T, Johnson DC, Seckinger A, Moreaux J, Försti A, et al. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells. Haematologica. 2015;100:e110–3.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ke J, Lou J, Chen X, Li J, Liu C, Gong Y, et al. Identification of a functional variant for colorectal cancer risk mapping to chromosome 5q31.1. Oncotarget. 2016;7:35199–207.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Closa A, Cordero D, Sanz-Pamplona R, Solé X, Crous-Bou M, Paré-Brunet L, et al. Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis. Carcinogenesis. 2014;35:2039–46.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Sun J, Wang X, Fu C, Wang X, Zou J, Hua H, et al. Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its natural antisense transcript FGFR3. Mol Biol Rep. 2016;43:427–36.CrossRefPubMedGoogle Scholar
  36. 36.
    Yang Y, Su Z, Song X, Liang B, Zeng F, Chang X, et al. Enhancer RNA-driven looping enhances the transcription of the long noncoding RNA DHRS4-AS1, a controller of the DHRS4 gene cluster. Sci Rep. 2016;6:20961.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R, et al. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 2016;373:251–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Altinoz MA, Elmaci I, Ince B, Ozpinar A, Sav AM. Hemorphins, and 11p15.5 chromosomal region in cancer biology and immunity with special emphasis for brain tumors. J Neurol Surg A Cent Eur Neurosurg. 2016;77:247–57.CrossRefPubMedGoogle Scholar
  39. 39.
    Li S, Li J, Tian J, Dong R, Wei J, Qiu X, et al. Characterization, tissue expression, and imprinting analysis of the porcine CDKN1C and NAP1L4 genes. J Biomed Biotechnol. 2012;2012:946527.PubMedPubMedCentralGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2017

Authors and Affiliations

  • Tian Tian
    • 1
    • 2
  • Ling Xiao
    • 2
  • Jiangbo Du
    • 2
    • 3
  • Xun Zhu
    • 2
  • Yayun Gu
    • 2
  • Na Qin
    • 2
  • Caiwang Yan
    • 2
  • Li Liu
    • 4
  • Hongxia Ma
    • 2
    • 3
  • Yue Jiang
    • 2
    • 3
  • Jiaping Chen
    • 2
    • 3
  • Hao Yu
    • 2
  • Juncheng Dai
    • 2
    • 3
  1. 1.Department of Epidemiology and Biostatistics, School of Public HealthNantong UniversityNantongChina
  2. 2.Department of Epidemiology and Biostatistics, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public HealthNanjing Medical UniversityNanjingChina
  3. 3.Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment Collaborative Innovation Center of Cancer MedicineNanjing Medical UniversityNanjingChina
  4. 4.Digestive Endoscopy CenterThe First Affiliated Hospital of Nanjing Medical University and Jiangsu Province HospitalNanjingChina

Personalised recommendations